Trial Design Solutions

  1. Early Phase Trials In Australia 9/6/2024

    Australia is a preferred destination for early phase trials because of simple and fast regulatory stream and lucrative R&D cash refund scheme.

  2. Drug Development Experience For Biotechs 8/8/2024

    Leverage our extensive expertise across over 120 therapeutic indications to drive your success.

  3. Clinical Trial Site Selection And Management 7/25/2024

    Our network of 150+ active clinical trial sites allows us to identify potential partners that align with your therapeutic area, geographic preference, and specialty population requirements.

  4. Central IRB Services 4/10/2025

    “Going the extra mile is a big part of our DNA. Personal attention can go a long way in ensuring the success of your next research study.”

    Raffaella Hart, MS, CIP
    Sr. Vice President, IRB and IBC Services

    Fast, reliable IRB review for multisite studies backed by expert oversight and responsive support. With streamlined submissions, frequent meetings, and dedicated client managers, BRANY IRB helps you save time and money while maintaining full regulatory compliance.

  5. IRB Review Services For Phase I Research 12/22/2021

    With experience overseeing thousands of Phase I studies in the US and Canada, Advarra’s institutional review board (IRB) understands the unique requirements of Phase I study design and conduct. Our dedicated team and processes are built to support your Phase I research needs.

  6. Drive Patient Enrollments With Data-Powered Recruitment Engine 12/13/2024

    Generate consistent, successful clinical trial recruitment on repeat with Citeline Connect's multifaceted approach to patient engagement and recruitment.

  7. Engaging, Empowering & Supporting Research Sites Around The World 3/19/2025

    Accelerate trial timelines and recruitment while reducing site burden through this site network solution.

  8. Accelerating Trial Enrollment With Data-Driven Outreach 2/21/2025

    Address critical challenges with patient enrollment, including difficulties in identifying eligible participants which often leads to delays and increased costs.

  9. How Trial Compass Is Solving Psychiatric Trial Enrollment 9/25/2025

    Psychiatric trials have long been among the most difficult to enroll. From treatment-resistant depression (TRD) and PTSD to cognitive and neuro disorders, sponsors are facing the same challenges over and over again:

    • Narrow I/E criteria that don’t translate into real-world patients
    • Sites with limited behavioral health infrastructure
    • Lack of patient trust and trial awareness in psychiatric populations
    • Professional patients
    • Rating scales aren’t used in clinical practices

    But what if recruitment didn’t have to start with a gamble?

  10. Selecting The Right Pain Model For Early Phase Analgesic Trials 1/26/2023

    Altasciences’ pain experts and neuroscientists are here to guide you in selecting the most appropriate pain model to successfully evaluate the efficacy and safety profile of your study drug.